Chris Wood (Reveal-Dx)
Overview
Chris Wood is a pioneering entrepreneur in the field of medical imaging and artificial intelligence. He is best known for his role as the CEO and Chair of the Board at Reveal-Dx, a Seattle-based company focused on improving lung cancer diagnostics through advanced radiomics and AI-enabled decision support software. With a career spanning over three decades in medical imaging, Wood has been instrumental in bringing groundbreaking technologies to the market, notably being part of the first team to achieve FDA clearance for automated cancer detection in Breast MRI through his previous venture, Confirma.
Recent Developments
From 2023 to 2025, several key developments have shaped Chris Wood’s journey and Reveal-Dx’s progress:
- April 2025: Chris Wood was featured in Authority Magazine discussing the impact of AI on medical imaging and its potential to personalize medicine, emphasize patient care, and improve diagnostic accuracy across the board (Authority Magazine).
- July 2024: Reveal-Dx raised $4.25 million to enhance its software that helps clinicians diagnose lung cancer more effectively. The funding round was aimed at expanding the company’s reach in Europe and securing FDA approval in the United States (GeekWire).
- 2024: Under Wood’s leadership, Reveal-Dx obtained the CE Mark and a Health Canada medical device license for its RevealAI-Lung product, a testament to the product's clinical validation on an international scale (Reveal-Dx Leadership).
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Chris Wood |
| Born | Information not publicly available |
| Nationality | American |
| Occupation | CEO, Chair of the Board, Entrepreneur |
| Known For | AI in Medical Imaging and Radiomics |
| Education | MS in Physics, University of South Florida (1987-1989) (RocketReach) |
Early Life and Education
Chris Wood’s early life was significantly influenced by a personal encounter with diagnostic uncertainty when his mother underwent treatment for breast cancer. This formative experience played a pivotal role in shaping his interest in diagnostic imaging. Initially inclined towards science from a young age, Wood pursued a Master of Science in Physics at the University of South Florida, which laid the foundation for his innovative work in medical imaging (Authority Magazine).
Career and Notable Achievements
Chris Wood kickstarted his career at Picker International, gaining invaluable experience in the medical imaging industry. His deep involvement in AI and medical imaging technologies led him to co-found Confirma in 2000, introducing the first computer-aided detection software for breast MRI, contributing significantly to the adoption of this diagnostic technology.
- Confirma: Co-founder of the company, instrumental in achieving widespread use of Breast MRI testing.
- Clario Medical Imaging: Founder; focused on improving worklists for radiologists.
- Reveal-Dx: As CEO and Chairman, Wood is leading the charge in developing AI solutions for radiology problems, notably in lung cancer detection.
Current Work and Impact
Currently, Chris Wood is at the helm of Reveal-Dx, pushing the frontiers of artificial intelligence in medical imaging. His work continues to influence the diagnosis and treatment of lung cancer. Under his leadership, Reveal-Dx is developing AI tools that promise to streamline diagnostic processes, reduce unnecessary medical procedures, and lower healthcare expenses, while enhancing patient outcomes.
Conclusion
Chris Wood stands out as a visionary leader in the AI and medical imaging sectors. His innovative contributions, particularly through Reveal-Dx, are set to improve lung cancer detection and overall patient care standards. Looking forward, Wood’s efforts in AI and radiomics continue to hold the promise of furthering the integration of cutting-edge technology into everyday medical diagnostics, reinforcing his impact on the industry.